Search Result

Results for "

MAb

" in MedChemExpress (MCE) Product Catalog:

By Targets:	ADAMTS (1) ADC Antibody (4) ADC Linker (2) ADC Payload (2) Akt (1) Amyloid-β (1) Anaplastic lymphoma kinase (ALK) (1) Antibiotic (1) Antibody-Drug Conjugates (ADCs) (6) Apoptosis (7) Bacterial (8) Biochemical Assay Reagents (4) c-Fms (4) c-Kit (1) c-Myc (1) C-type Lectin-like Receptors (CTLRs) (4) Cadherin (2) Calcium Channel (1) CCR (2) CD19 (1) CD20 (2) CD22 (2) CD28 (2) CD3 (2) CD47 (3) CD6 (1) CD73 (5) CDK (1) Checkpoint Kinase (Chk) (1) CMV (1) Complement System (3) CXCR (5) DNA/RNA Synthesis (4) Drug-Linker Conjugates for ADC (1) EGFR (6) ERK (1) Estrogen Receptor/ERR (1) Factor Xa (1) Fc Receptor (FcR) (1) Ferroptosis (1) FGFR (1) Filovirus (2) GCGR (1) Glycoprotein VI (1) HBV (1) HCV (1) Histamine Receptor (1) HIV (7) IFNAR (7) IGF-1R (3) Influenza Virus (6) Integrin (3) Interleukin Related (25) JAK (1) LAG-3 (7) LPL Receptor (2) MDM-2/p53 (1) Mesothelin (1) MHC (1) Microtubule/Tubulin (2) MMP (4) Mucin (3) Myosin (1) nAChR (1) Neurokinin Receptor (1) NF-κB (2) NO Synthase (1) Notch (3) NTPDase (1) Orexin Receptor (OX Receptor) (7) P-selectin (1) PAI-1 (2) PCSK9 (2) PD-1/PD-L1 (23) Phosphatase (1) Proteasome (1) PSMA (2) Radionuclide-Drug Conjugates (RDCs) (1) Reactive Oxygen Species (ROS) (1) RSV (8) SARS-CoV (15) Ser/Thr Protease (1) Sialyltransferase (1) Small Interfering RNA (siRNA) (5) STAT (3) Tau Protein (5) TGF-beta/Smad (3) TGF-β Receptor (5) Thyroid Hormone Receptor (1) Tie (2) Tim3 (3) Tissue Factor Pathway Inhibitor (TFPI) (1) TNF Receptor (29) Toll-like Receptor (TLR) (4) Topoisomerase (1) Transferrin Receptor (2) Transmembrane Glycoprotein (27) Transthyretin (TTR) (2) TREM receptor (1) Trk Receptor (7) TROP2 (2) VEGFR (10) VISTA (2) Wnt (4)
By Research Areas:	Cancer (190) Cardiovascular Disease (7) Endocrinology (8) Infection (50) Inflammation/Immunology (72) Metabolic Disease (8) Neurological Disease (19)
Oligonucleotides:	Rat Pre-designed siRNA Sets (1) Mouse Pre-designed siRNA Sets (1) Human Pre-designed siRNA Sets (3) siRNAs (5)

323

Inhibitors & Agonists

Screening Libraries

Biochemical Assay Reagents

Peptides

293

Inhibitory Antibodies

Natural
Products

Recombinant Proteins

Antibodies

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-150637

Mab Aspartate Decarboxylase-IN-1	Bacterial	Infection
Mab Aspartate Decarboxylase-IN-1 is a potent aspartate decarboxylase (PanD) inhibitor with an IC₅₀ value of 56.3 μM. Mab Aspartate Decarboxylase-IN-1 shows antibacterial activity .

HY-P99283

Concizumab 1 Publications Verification NN 7415; MAb 2021; Anti-TFPI Recombinant Antibody	Factor Xa	Others
Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that binds to the Kunitz-type protease inhibitor (KPI) 2 structural domain of TFPI, thereby blocking the interaction of this structural domain with the FXa active site. Concizumab can be used in the study of haemophilia .

HY-P99337

Ansuvimab AnsuviMAb-zyk; MAb114	Filovirus	Infection
Ansuvimab (Ansuvimab-zyk) is a recombinant human monoclonal IgG1 antibody that exhibits antiviral activity against Zaire ebolavirus. Ansuvimab binds to the glycoprotein on Zaire ebolavirus to block its entry into host cells .

HY-P991328

MAb604.107	Notch	Cancer
MAb604.107 is a human monoclonal antibody (mAb) targeting NOTCH1. MAb604.107 inhibits the proliferation and CD34/CD44 expression of primary T-ALL cells. MAb604.107 has anti-tumor activity in four tumor xenograft mouse models: MDA-MB-231, HCC-1806, BT-474, and HCT-116. MAb604.107 can be used in T acute lymphoblastic leukemia research .

HY-157433

Mab-SaS-IN-1	Bacterial	Infection
Mab-SaS-IN-1 (compoud 1H) is *Mab-SaS* inhibitor with the IC₅₀ of 2 μM. Mab-SaS-IN-1 can be used for study of antibiosis by blocking iron uptake and metabolism .

HY-RS07939

MAB21L2 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MAB21L2 Human Pre-designed siRNA Set A contains three designed siRNAs for MAB21L2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAB21L2 Human Pre-designed siRNA Set A MAB21L2 Human Pre-designed siRNA Set A

HY-RS07940

MAB21L3 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MAB21L3 Human Pre-designed siRNA Set A contains three designed siRNAs for MAB21L3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAB21L3 Human Pre-designed siRNA Set A MAB21L3 Human Pre-designed siRNA Set A

HY-RS07938

MAB21L1 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MAB21L1 Human Pre-designed siRNA Set A contains three designed siRNAs for MAB21L1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAB21L1 Human Pre-designed siRNA Set A MAB21L1 Human Pre-designed siRNA Set A

HY-RS20637

Mab21l2 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Mab21l2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Mab21l2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Mab21l2 Mouse Pre-designed siRNA Set A Mab21l2 Mouse Pre-designed siRNA Set A

HY-RS27146

Mab21l2 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Mab21l2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Mab21l2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Mab21l2 Rat Pre-designed siRNA Set A Mab21l2 Rat Pre-designed siRNA Set A

HY-P990110

Lecanemab (Mouse IGG2a) MAb158	Amyloid-β	Neurological Disease
Lecanemab (Mouse IGG2a) is a monoclonal antibody that targets soluble β-amyloid and has the potential to reduce cognitive decline. The variable region of Lecanemab (Mouse IGG2a) is consistent with that of Lecanemab, while the constant region is of Mouse IGG2a sequence. Lecanemab (Mouse IGG2a) holds promise for research in the field of Alzheimer's disease .

HY-P99825

Relfovetmab	TNF Receptor	Neurological Disease Inflammation/Immunology
Relfovetmab is an anti-NGF monoclonal antibody (mAb) .

HY-P99506

Tamrintamab SC-003 MAb; SC-MAb003; SC34.28ss1	ADC Antibody	Cancer
Tamrintamab (SC-003 mAb, SC-Mab003, SC34.28ss1) is an ADC Antibody targeting to dipeptidase 3 (DPEP3 or MBD3). DPEP3 is a glycosyl phosphatidylinositol anchored metallopeptidase that is overexpressed in ovarian tumors. Tamrintamab can specifically bind DPEP3-expressing cells to produce cytotoxicity. Tamrintamab can be used in ovarian cancer research .

HY-P991547

*Anti-CD20 Antibody (mAb* 1.5.3)**	CD20 Apoptosis	Inflammation/Immunology Cancer
Anti-CD20 Antibody (mAb 1.5.3) is a fully human IgG1 anti-CD20 antibody. Anti-CD20 Antibody (mAb 1.5.3) evokes enhanced pro-apoptotic activity in vitro. Anti-CD20 Antibody (mAb 1.5.3) mediated both complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity. Anti-CD20 Antibody (mAb 1.5.3) demonstrates enhanced anti-tumor activity in various tumor xenograft models. Anti-CD20 Antibody (mAb 1.5.3) produces a superior B-cell depletion profile in lymph node organs and bone marrow in a primate pharmacodynamic model. Anti-CD20 Antibody (mAb 1.5.3) can be studied in research for B-cell maglignancies .

HY-P990302

*Anti-Human/Rat/Fish AChR Antibody (Mab35)*	nAChR	Neurological Disease
Anti-Human/Rat/Fish AChR Antibody (Mab35) is an anti-human/rat/fish AChR IgG1 monoclonal antibody. Anti-Human/Rat/Fish AChR Antibody (Mab35) can attack the AChR of neuromuscular junctions. Anti-Human/Rat/Fish AChR Antibody (Mab35) can be used for the construction of myasthenia gravis models .

HY-157234

*AC mAb-X purification resin*	Biochemical Assay Reagents	Others
AC mAb-X purification resin is a special protein A resin. Matrix: high rigidity agarose; particle size: 40~120 μm; ligand: recombinant alkali-resistant Protein A (~24KD); ADC purification resin.

HY-P990894

*Anti-DM1 antibody(14E3) (Rabbit mAb)*	Microtubule/Tubulin ADC Payload	Cancer
Anti-DM1 antibody (14E3) (Rabbit mAb) is a rabbit-derived IgG type antibody, targeting to DM1 (HY-19792). Anti-DM1 antibody (14E3) (Rabbit mAb) can be used for ELISA experiment in species independent background.

HY-P9801

Anti-Spike-RBD mAb 1 Publications Verification SARS-CoV-2 (2019-nCoV) Spike RBD Antibody	SARS-CoV	Infection
Anti-Spike-RBD mAb is a CHO cell derived human monoclonal IgG1 antibody. Blocking the interaction of Spike protein and ACE2. Anti-Spike-RBD mAb is a potential therapeutic approach for SARS-CoV-2 treatment .

HY-163010

Dicamba-propionic acid	Biochemical Assay Reagents	Others
Dicamba-propionic acid (DCa3) is a heterologous hapten that can be used to develop high-affinity monoclonal antibodies (mAb) against Dicamba. The Dicamba-propionic acid- developed mAb can be used to determine the residual amount of Dicamba in environmental water samples .

HY-157257

Trimethoprim fumaric acid	Biochemical Assay Reagents	Others
Trimethoprim fumaric acid (Compound CDI) is a universal hapten for ASGs (Antibacterial synergists) and can be used to design broadly specific monoclonal antibodies (mAbs) against ASGs. The mAb developed by Trimethoprim fumaric acid can be applied in ELISA to detect the residues of ASGs in foods of animal origin .

HY-P9803

Anti-SARS-80R mAb SARS-80R; SARS Antibody-80R	SARS-CoV	Infection
Anti-SARS-80R mAb (SARS-80R) is a human monoclonal IgG1 antibody produced in CHO cells. Anti-SARS-80R mAb can specifically bind to Spike (S1) protein to prevent SARS virus infection of susceptible cells .

HY-P9806

Anti-MERS-D12 mAb MERS-D12; MERS Antibody-D12	SARS-CoV	Infection
Anti-MERS-D12 mAb (MERS-D12; MERS Antibody-D12) is a human monoclonal IgG1. Anti-MERS-D12 mAb binds directly to the DPP4 interacting region of the MERS-CoV Spike receptor binding domain (RBD) and effect neutralization by directly blocking receptor binding .

HY-P9805

Anti-MERS-3A1 mAb MERS-3A1; MERS Antibody-3A1	SARS-CoV	Infection
Anti-MERS-3A1 mAb (MERS-3A1) is a human monoclonal IgG1 antibody with the high binding affinity produced in CHO cells. Anti-MERS-3A1 mAb bocks the binding of MERS-CoV spike protein to DPP4 receptor .

HY-P99480

Bintrafusp alfa M7824; MSB0011359C	TGF-β Receptor	Cancer
Bintrafusp alfa (M 7824) is a first-in-class bifunctional fusion protein composed of the extracellular domain of TGF-βRII fused to a human IgG1 mAb blocking programmed cell death ligand. Bintrafusp alfa can be used for the research of cancer .

HY-P9802

Anti-Spike-RBD Single Domain mAb SARS-CoV-2 (2019-nCoV) Single-Domain Antibodies; Humanized Single Domain Antibody	SARS-CoV	Infection
Anti-Spike-RBD Single Domain mAb is a CHO cell derived Alpaca monoclonal VHH-huFc antibody, specifically binds to SARS-CoV-2 RBD with high affinity .

HY-P99006

Amatuximab MORab-009	Mesothelin	Cancer
Amatuximab (MORab-009) is a chimeric, humanized IgG1/k MAb that targets the cell surface mesothelin (MSLN). Mesothelin is a glycosylphosphatidyl inositol (GPI)-anchored membrane glycoprotein, which is present in a restricted set of normal adult tissues such as the mesothelium .

HY-P9807

*Anti-SARS-CoV-2 Spike mAb* (CR3022)** SARS-CR3022; SARS-CoV-2 Antibody-CR3022	SARS-CoV	Infection Inflammation/Immunology
Anti-SARS-CoV-2 Spike mAb (CR3022) is a a CHO cell derived human monoclonal IgG1 antibody. It binds to both S1 domain of SARS-CoV/SARS-CoV-2 Spike protein .

HY-132158

MC-AAA-NHCH2OCH2COO-7-aminomethyl-10-methyl-11-fluoro camptothecin	Drug-Linker Conjugates for ADC	Cancer
MC-AAA-NHCH2OCH2COO-7-aminomethyl-10-methyl-11-fluoro camptothecin (compound 21a), a camptothecin payload, can be conjugated to a monoclonal antibody (mAb) for the synthesis of camptothecin antibody-drug conjugate (ADC) .

HY-P99351

Andecaliximab Anti-MMP9 Reference Antibody (andecalixiMAb)	MMP	Cancer
Andecaliximab is a recombinant chimeric IgG4 monoclonal antibody (mAb) targets matrix metalloproteinase 9 (MMP9). Andecaliximab shows the antifibrotic efficacy in idiopathic pulmonary fibrosis mouse models. Andecaliximab can be used for the research of gastric adenocarcinoma and idiopathic pulmonary fibrosis (IPF) .

HY-132260

Naratuximab emtansine IMGN529; Debio 1562	Antibody-Drug Conjugates (ADCs) Apoptosis	Cancer
Naratuximab emtansine (IMGN529) is a CD37-targeted ADC consisting of a humanized IgG1 mAb coupled to the microtubule disruptor DM1. Naratuximab emtansine has high affinity and specificity for CD37, allowing ADC internalization, processing and intracellular release of DM1. Due to its ability to disrupt microtubule assembly, DM1 can subsequently induce cell cycle arrest and apoptosis .

HY-16707

CH 5450 Z-Ile-Glu-Pro-Phe-Ome	Proteasome	Inflammation/Immunology
CH 5450 (Z-Ile-Glu-Pro-Phe-Ome) is a selective short peptide human cardiac chymase inhibitor. CH-5450 inhibits the action of rat MAB elastase 2 on substrate Ang I with an IC₅₀ value of 49 µM and N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide with an IC₅₀ value of 4.8 µM .

HY-P9804

Anti-MERS-2E6 mAb MERS-2E6; MERS Antibody-2E6	SARS-CoV	Infection
Anti-MERS-2E6 mAb (MERS-2E6; MERS Antibody-2E6), a human neutralizing antibody IgG1 (CHO expressed) that can compete for the binding of the virus Spike protein to the receptor (CD26), thereby inhibiting virus invasion into host cells.

HY-P99297

Bedinvetmab ZTS-00508841	Trk Receptor	Inflammation/Immunology
Bedinvetmab (ZTS-00508841) is a canine monoclonal antibody (mAb) targeting nerve growth factor (NGF). Bedinvetmab inhibits NGF interaction with tropomyosin receptor kinase A (trkA) and p75 neurotrophin receptor (p75NTR) receptors. Bedinvetmab can be used for the research of osteoarthritis pain in dogs .

HY-P4025

ELDKWA	HIV	Others
ELDKWA is the highly conserved amino acids on the ecto-domain of gp41. ELDKWA acts as the epitope of a neutralizing monoclonal antibody 2F5 (mAb 2F5) directed against human immunodeficiency virus type 1 .

HY-P99729

Melrilimab GSK 3772847; CNTO-7160	Interleukin Related	Inflammation/Immunology
Melrilimab (GSK 3772847) is an IgG2-kappa anti-IL1RL1/ST2/IL33R/DER4/FIT-1 monoclonal antibody. Melrilimab can be used for the research of asthma .

HY-176730

HC2210	Bacterial	Infection
HC2210 has an antibacterial effect against Mycobacterium abscessus (Mab) (EC₅₀: 0.72 µM). HC2210 modulates the expression of Mab genes related to oxidative stress and lipid metabolism. HC2210 can be used in the study of Mab infection .

HY-P991508

Sym004	EGFR	Cancer
Sym004 is a 1:1 mixture of two recombinant, human-mouse chimeric mAbs directed against nonoverlapping EGFR epitopes (mAb992 and mAb1024). Sym004 is ability to mediate rapid EGFR internalization and subsequent degradation of internalized receptors via EGFR cross-linking. Sym004 can be used for the study of metastatic colorectal cancer, head and neck (H&N) and lung cancer .

HY-P99558

Timigutuzumab GEXMAb73; GT-MAb7.3-GEX; TrastuzuMAb-GEX	EGFR	Cancer
Timigutuzumab (GEXMab73) is a humanized monoclonal antibody that targets ErbB2. Timigutuzumab can be used for the research of cancer .

HY-143482

MMV688844	Bacterial DNA/RNA Synthesis	Infection
MMV688844 is a potent Mycobacterium abscessus (Mabs) DNA Gyrase inhibitor with an IC₅₀ value of 2 μM. MMV688844 has bactericidal properties against Mabs bamboo with a MIC₅₀ of 12 μM. MMV688844 can be used for researching anti-bacteria .

HY-P99287

Elsilimomab B-E8; Anti-IL-6 MAb B-E8	Interleukin Related	Inflammation/Immunology Cancer
Elsilimomab (B-E8) is a IgG1 monoclonal antibody against interleukin-6 (IL-6), with a K_D of 22 pM and an IC₅₀ of 1.4 nM. Elsilimomab can be used for the research of multiple myeloma, renal cell carcinoma, and rheumatoid arthritis (RA) .

HY-P99450

Avdoralimab IPH 5401; Anti-C5aR1 MAb	Complement System	Inflammation/Immunology Cancer
Avdoralimab (IPH 5401) is a fully human IgGκ monoclonal antibody that targets the complement C5a receptor 1 (C5aR1) that prevents its binding to C5a. Avdoralimab can be used for complement-driven inflammatory diseases and solid tumours research .

HY-P99401

Rosmantuzumab OMP-131R10	Wnt	Cancer
Rosmantuzumab (OMP-131R10) is an anti-R-spondin 3 (RSPO3) humanized monoclonal antibody. Rosmantuzumab can be used for the research of advanced telapsed and refractory solid tumors .

HY-143483

NBTIs-IN-5	Bacterial	Infection
NBTIs-IN-5 (Compound 5r) is a NBTI (Novel Bacterial Topoisomerase Inhibitor) DNA gyrase inhibitor with an IC₅₀ of 1.5 μM against Mycobacterium abscessus (Mabs) DNA gyrase. NBTIs-IN-5 inhibits Mabs bamboo bacterial growth with an MIC₉₀ of 0.4 μM .

HY-P99608

Exbivirumab	HBV	Infection
Exbivirumab is an anti-HBV mAb. Exbivirumab enhances the antiviral activity of hepatitis B immunoglobulin (HBIG) .

HY-P99808

Pulocimab	VEGFR	Cancer
Pulocimab is an anti-VEGFR2 monoclonal antibody (mAb). Pulocimab can be used for the research of cancers .

HY-P99611

Faralimomab 64G12	IFNAR	Inflammation/Immunology
Faralimomab (64G12) is an immunomodulator, and a murine anti-IFNA1 IgG1 mAb .

HY-P991379

MG1113A	Tissue Factor Pathway Inhibitor (TFPI)	Others
MG1113A is a human monoclonal antibody (mAb) targeting TFPI. MG1113A can be used in Haemophilia research.

HY-P991299

ENUM006	LAG-3	Cancer
ENUM006 is a human monoclonal antibody (mAb) targeting CD223/LAG3 .

HY-P991298

DNV-3	LAG-3	Cancer
DNV-3 is a human monoclonal antibody (mAb) targeting CD223/LAG3 .

HY-P991360

MLN 591 MLN2704 antibody	PSMA	Cancer
MLN 591 is a human monoclonal antibody (mAb) targeting PSMA. MLN 591 can be used in Prostate cancer research .

Cat. No.	Product Name

HY-L031

Small Molecule Immuno-Oncology Compound Library

650 compounds

Immuno-Oncology is a type of immunotherapy that has the specific purpose of treating cancer. It works by stimulating our immune system to fight back. Normally, our immune system is able to destroy cancer cells in our body, however sometimes cancer cells can adapt and mutate, effectively hiding from our immune system. This is when tumors can develop and become a threat to our health. Immuno-oncology involves mobilizing lymphocytes to recognize and eliminate cancer cells using the body’s immune system. There are several immuno-oncology treatments available, including Immune cell therapy (CAR-T), monoclonal antibodies (mABs) and checkpoint inhibitors, cytokines and cancer vaccines.

MCE Small Molecule Immuno-Oncology Compound Library offers 650 bioactive tumor immunology compounds that target some important checkpoints such as PD1/PD-L1, CXCR, Sting, IDO, TLR, etc. This library is a useful tool for Immuno-oncology research.

Cat. No.	Product Name	Type

HY-D1056A3

Lipopolysaccharides, from E. coli O26:B6

LPS, from Escherichia coli (O26:B6)

Carbohydrates

Lipopolysaccharides, from E. coli (Escherichia coli) O26:B6 are lipopolysaccharide endotoxins and TLR-4 activators derived from E. coli, classified as S-type LPS, which can activate pathogen-associated molecular patterns (PAMP) of the immune system and induce cellular secretion of migrasomes. Lipopolysaccharides, from E. coli O26:B6 exhibit a typical three-part structure: O-antigen (O-antigen), core oligosaccharide (core oligosaccharide), and lipid A (Lipid A), and can be recognized by the core-specific monoclonal antibody MAb J8-4C10. Lipopolysaccharides, from E. coli O26:B6 can promote an increase in pro-inflammatory cytokines in plasma, thereby triggering hypothalamic-pituitary-adrenal (HPA) activation and leading to adrenal oxidative damage. The pathogenic effects of Lipopolysaccharides, from E. coli O26:B6 can be blocked by PD149163 (HY-123434) .
It is recommended to prepare a stock solution of ≥2 mg/mL and ensure that it is fully mixed and dissolved. Due to the adsorption characteristics of LPS, low adsorption centrifuge tubes should be used for aliquoting and storage.

Cat. No.	Product Name	Target	Research Area

HY-16707

CH 5450 Z-Ile-Glu-Pro-Phe-Ome	Proteasome	Inflammation/Immunology
CH 5450 (Z-Ile-Glu-Pro-Phe-Ome) is a selective short peptide human cardiac chymase inhibitor. CH-5450 inhibits the action of rat MAB elastase 2 on substrate Ang I with an IC₅₀ value of 49 µM and N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide with an IC₅₀ value of 4.8 µM .

HY-P4025

ELDKWA	HIV	Others
ELDKWA is the highly conserved amino acids on the ecto-domain of gp41. ELDKWA acts as the epitope of a neutralizing monoclonal antibody 2F5 (mAb 2F5) directed against human immunodeficiency virus type 1 .

HY-P10976

Spike Glycoprotein (1147-1162)	SARS-CoV	Infection
Spike Glycoprotein (1147-1162) is a linear and broadly neutralizing peptide in the S2 protein of SARS-CoV-2. Spike Glycoprotein (1147-1162) is conserved across SARS-CoV, BatCoV RaTG13, SARS-CoV-2, and SARS-CoV-2 variants. Spike Glycoprotein (1147-1162)-targeting mAbs can neutralize both SARS-CoV-2 and SARS-CoV by preventing fusion between the virus and cell membrane. Spike Glycoprotein (1147-1162) can be used for universal vaccines against SARS-CoV-2 mutants research .

Species:	Human (4) Mouse (1)
Tag:	His (5) SUMO (1)
Source:	CHO (1) E. coli (5)

Cat. No.	Compare	Product Name	Species	Source

HY-P77074

	MAB21L2 Protein, Human (His) Protein MAb-21-like 2; MAb21L2	Human	E. coli
	MAB21L2 protein, encoded by the MAB21L2 gene, is similar to the C. elegans MAB-21 gene, involved in neural fate determination. It is primarily found in the nucleus and occasionally in the cytoplasm, potentially playing a role in neural development. MAB21L2 Protein, Human (His-ZZ) is the recombinant human-derived MAB21L2 protein, expressed by E. coli , with N-His labeled tag.

HY-P71597

	cGAS Protein, Human (His-SUMO) 1 Publications Verification C6orf150; cGAMP synthase; cGAS; CGAS_HUMAN; cGMP Synthase; Chromosome 6 open reading frame 150; Cyclic GMP-AMP synthase; h-cGAS; Hypothetical protein LOC115004; MAb 21 domain containing 1; MAb-21 domain-containing protein 1; MB21D1; MGC131892; MGC142166; MGC142168; OTTHUMP00000016743; OTTHUMP00000039330; protein MB21D1; Uncharacterized protein C6orf150	Human	E. coli
	The cGAS protein is a nucleotidyl transferase that crucially mediates innate immunity by catalyzing the formation of 2',3'-cGAMP from ATP and GTP upon binding to double-stranded DNA (dsDNA). As a DNA sensor, cGAS detects exogenous and endogenous DNA, triggering STING1 activation and type I interferon production. cGAS Protein, Human (His-SUMO) is the recombinant human-derived cGAS protein, expressed by E. coli , with N-6*His, N-SUMO labeled tag.

HY-P72337

	cGAS Protein, Human (His) 1 Publications Verification Cyclic GMP-AMP synthase; cGAMP synthase; h-cGAS; 2'3'-cGAMP synthase; MAb-21 domain-containing protein 1; MB21D1; C6orf150	Human	E. coli
	cGAS is a cytosolic DNA sensor. cGAS binds double-stranded DNA (dsDNA) and catalyzes the generation of cyclic guanosine-adenylate (cGAMP), which in turn activates the STING protein. cGAS induces the production of type I interferon (IFN-I) and pro-inflammatory cytokines. cGAS Protein, Human (His) is a recombinant cGAS protein expressed in E. coli with a C-6*His tag.

HY-P9806

	Anti-MERS-D12 mAb MERS-D12; MERS Antibody-D12	Others	CHO
	Anti-MERS-D12 mAb is a human monoclonal IgG1. It binds directly to the DPP4 interacting region of the MERS-CoV Spike receptor binding domain (RBD) and effect neutralization by directly blocking receptor binding.

HY-P705410

	cGAS Protein, Mouse (His) cGAMP synthase; cGAS; m-cGAS; MAb-21 domain-containing protein 1	Mouse	E. coli
	cGAS Protein, Mouse (His) is the recombinant mouse-derived cGAS protein, expressed by E. coli, with His tag.

HY-P703939

	cGAS Protein, Human (362a.a, His) C6orf150; cGAMP synthase; cGAS; CGAS_HUMAN; cGMP Synthase; Chromosome 6 open reading frame 150; Cyclic GMP-AMP synthase; h-cGAS; Hypothetical protein LOC115004; MAb 21 domain containing 1; MAb-21 domain-containing protein 1; MB21D1; MGC131892; MGC142166; MGC142168; OTTHUMP00000016743; OTTHUMP00000039330; protein MB21D1; Uncharacterized protein C6orf150	Human	E. coli
	The cGAS protein is a nucleotidyl transferase that crucially mediates innate immunity by catalyzing the formation of 2',3'-cGAMP from ATP and GTP upon binding to double-stranded DNA (dsDNA). As a DNA sensor, cGAS detects exogenous and endogenous DNA, triggering STING1 activation and type I interferon production. cGAS Protein, Human (362a.a, His) is the recombinant human-derived cGAS protein, expressed by E. coli, with N-6*His labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Compare	Product Name	Application	Reactivity

HY-P81481

	DMRT1 Antibody (YA1226) DMT1; DMRT1; DM domain expressed in testis protein 1; Doublesex- and MAb-3-related transcription factor 1	IHC-P	Human
	DMRT1 Antibody (YA1226) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1226), targeting DMRT1. DMRT1 Antibody (YA1226) can be used for IHC-P experiment in human background.